bf/NASDAQ:LIFE_icon.png

NASDAQ:LIFE

aTyr Pharma, Inc.

  • Stock

USD

Last Close

1.85

04/06 20:00

Market Cap

131.12M

Beta: 1.22

Volume Today

267.89K

Avg: 572.41K

PE Ratio

−2.34

PFCF: −2.62

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
422K
-
10.46M
2,377.49%
10.39M
-
353K
96.60%
cost of revenue
14.05M
-
17.29M
23.09%
1.30M
92.46%
1.70M
29.98%
2.74M
61.71%
gross profit
-13.63M
-
-6.84M
49.83%
-1.30M
80.92%
8.69M
766.49%
-2.39M
127.48%
selling and marketing expenses
-2.74M
-
general and administrative expenses
5.71M
-
6.78M
18.69%
13.11M
93.48%
15.09M
15.12%
17.08M
13.14%
12.44M
27.19%
9.35M
24.79%
9.07M
2.96%
10.75M
18.47%
13.98M
30.05%
12.98M
7.17%
selling general and administrative expenses
5.71M
-
6.78M
18.69%
13.11M
93.48%
15.09M
15.12%
17.08M
13.14%
12.44M
27.19%
9.35M
24.79%
9.07M
2.96%
10.75M
18.47%
13.98M
30.05%
10.24M
26.78%
research and development expenses
13.83M
-
16.78M
21.29%
34.50M
105.66%
42.85M
24.18%
30.07M
29.83%
20.39M
32.20%
14.05M
31.09%
17.29M
23.09%
23.26M
34.54%
42.81M
84.01%
42.29M
1.20%
other expenses
-357K
-
-1.06M
-
-1.70M
59.60%
-785K
53.69%
-319K
59.36%
238K
174.61%
1.06M
345.80%
4.52M
326.20%
cost and expenses
19.54M
-
23.55M
20.53%
47.62M
102.16%
57.94M
21.68%
47.15M
18.63%
32.82M
30.38%
23.40M
28.70%
26.37M
12.68%
34.02M
29.01%
56.79M
66.96%
55.27M
2.67%
operating expenses
19.54M
-
23.55M
20.53%
47.62M
102.16%
57.94M
21.68%
47.15M
18.63%
32.82M
30.38%
23.40M
28.70%
26.37M
12.68%
34.02M
29.01%
56.79M
66.96%
52.53M
7.50%
interest expense
-444K
-
-832K
87.39%
-386K
53.61%
65K
116.84%
-1.70M
-
ebitda
-18.80M
-
-22.76M
21.07%
-47.62M
109.20%
-57.91M
21.62%
-47.15M
18.59%
-32.82M
30.38%
-22.98M
29.99%
-15.91M
30.76%
-34.02M
113.78%
-46.40M
36.42%
-52.18M
12.44%
operating income
-19.54M
-
-23.55M
20.53%
-47.62M
102.16%
-57.94M
21.68%
-47.15M
18.63%
-32.82M
30.38%
-22.98M
29.99%
-15.91M
30.76%
-34.02M
113.78%
-46.40M
36.42%
-54.92M
18.35%
depreciation and amortization
714K
-
829K
16.11%
869K
4.83%
900K
3.57%
713K
20.78%
746K
4.63%
1.37M
83.11%
1.27M
7.32%
1.30M
3.00%
1.70M
29.98%
2.74M
61.71%
total other income expenses net
-28K
-
36K
228.57%
-357K
1,091.67%
-29K
91.88%
-1.06M
3,562.07%
-1.70M
59.60%
-785K
53.69%
-319K
59.36%
238K
174.61%
1.06M
345.80%
4.52M
326.20%
income before tax
-20.01M
-
-24.35M
21.66%
-47.97M
97.01%
-57.90M
20.70%
-48.21M
16.75%
-34.52M
28.40%
-23.76M
31.15%
-16.23M
31.70%
-33.78M
108.11%
-45.34M
34.24%
-50.40M
11.15%
income tax expense
472K
-
796K
68.64%
-869K
209.17%
-49K
94.36%
-713K
1,355.10%
-1.70M
137.73%
-1.53M
9.97%
-1.27M
16.64%
-1.31M
3.22%
-1.07M
18.81%
-8K
99.25%
net income
-20.01M
-
-24.35M
21.66%
-47.97M
97.01%
-57.85M
20.60%
-48.21M
16.68%
-34.52M
28.40%
-22.24M
35.57%
-14.96M
32.73%
-32.46M
117.03%
-44.28M
36.39%
-50.39M
13.80%
weighted average shs out
719.51K
-
719.51K
0%
1.13M
57.23%
1.69M
49.52%
1.84M
8.95%
2.14M
16.11%
3.36M
56.82%
9.16M
172.98%
19.08M
108.30%
28.42M
48.94%
53.61M
88.63%
weighted average shs out dil
719.51K
-
719.51K
0%
1.13M
57.23%
1.69M
49.52%
1.85M
9.08%
2.14M
16.09%
3.36M
56.66%
9.16M
172.98%
19.08M
108.30%
28.42M
48.94%
53.61M
88.63%
eps
-27.82
-
-33.84
21.64%
-42.40
25.30%
-34.20
19.34%
-26.13
23.60%
-16.13
38.27%
-6.63
58.90%
-1.63
75.41%
-1.70
4.29%
-1.56
8.24%
-0.94
39.74%
epsdiluted
-27.82
-
-33.84
21.64%
-42.40
25.30%
-34.20
19.34%
-26.13
23.60%
-16.11
38.35%
-6.63
58.85%
-1.63
75.41%
-1.70
4.29%
-1.56
8.24%
-0.94
39.74%

All numbers in USD (except ratios and percentages)